APA (7th ed.) Citation

D, Z., P, K., C, B., B, M., O, S., V, S., . . . S, T. (2026). Therapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: A critical appraisal. Diabetology & metabolic syndrome, 18(1), . https://doi.org/10.1186/s13098-026-02241-w

Chicago Style (17th ed.) Citation

D, Ziegler, Kempler P, Bala C, Mankovsky B, Schnell O, Spallone V, Stirban A, and Tesfaye S. "Therapeutic Potential of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Diabetic Neuropathy: A Critical Appraisal." Diabetology & Metabolic Syndrome 18, no. 1 (2026). https://doi.org/10.1186/s13098-026-02241-w.

MLA (9th ed.) Citation

D, Ziegler, et al. "Therapeutic Potential of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Diabetic Neuropathy: A Critical Appraisal." Diabetology & Metabolic Syndrome, vol. 18, no. 1, 2026, https://doi.org/10.1186/s13098-026-02241-w.